Supplementary Figure from Plasma CD27, a Surrogate of the Intratumoral CD27–CD70 Interaction, Correlates with Immunotherapy Resistance in Renal Cell Carcinoma
Nadine Benhamouda(Inserm), Éric Tartour(Centre National de la Recherche Scientifique), Chloé Broudin(Assistance Publique – Hôpitaux de Paris), Hang‐Phuong Pham(Pitié-Salpêtrière Hospital), Julien Adam(Inserm), Camille Nevoret(Inserm), Laëtitia Mauge(Inserm), Sandrine Katsahian(Inserm), Patrice Ravel(Inserm), Letuan Phan(Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie), Sébastien Mella(Centre National de la Recherche Scientifique), Joséphine Pineau(Inserm), Milena Hasan(Institut Pasteur), Nathalie Chaput(Institut Gustave Roussy), Valentina Libri(Institut Pasteur), Nadège Gruel(Inserm), Clémence Granier(Inserm), Valentin Quiniou(Inserm), Antonin Saldmann(Inserm), Stéphane Oudard(Assistance Publique – Hôpitaux de Paris), Arnaud Méjean(Hôpital Européen), Olivier Adotévi(Inserm), Laurence Albigès(Université Paris-Saclay), Ikuan Sam(Inserm), Éléonore De Guillebon(Inserm), Dominique Helley(Inserm), Alain Gey(Inserm), Nicolas Epaillard(Inserm), Virginie Verkarre(Université Paris Cité), Bernd Jabla(Centre National de la Recherche Scientifique), Yann Vano(Délégation Paris 5)
Cited by 1
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab
|Annals of Oncology|2017|1.3k
Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
|Clinical Cancer Research|2016|1.2k
Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung Cancer
|American Journal of Respiratory and Critical Care Medicine|2014|806